国际皮肤性病学杂志    2007 33 (5): 299-301   ISSN: 2096-5540  CN: 32-1880/R   先天性角化不良研究进展 邓伟平1, 莫友2, 王建琴2 1. 广东省人民医院皮肤科 广州 510080; 2. 广州市第一人民医院皮肤科 收稿日期 2006-12-05  修回日期 null  网络版发布日期 null 参考文献  [1] Vulliamy T,Marrone A,Goldman F,et al.The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita.Nature,2001,413 (6854):432-435. [2] Heiss NS,Girod A,Salowsky R,et al.Dyskerin localizes to the nucleolus and its mislocalization is unlikely to play a role in the pathogenesis of dyskeratosis congenita.Hum Mol Genet,1999,8(13):2515-2524. [3] Walne AJ,Marrone A,Dokal I.Dyskeratosis congenita:a disorder of defective telomere maintenance? Int J Hematol,2005,82(3):184-189. [4] Armanios M,Chen JL,Chang YP,et al.Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita.Proc Nail Ac ad Sci U S A,2005,102(44):15960-15964. [5] Vulliamy T,Dokal I.Dyskeratosis congenita.Semin Hematol,2006,43 (3):157-166. [6] Fleisig HB,Wong JM.Telomerase as a clinical target:current strategies and potential applications.Exp Gerontol.2007,42(1-2):102-12. [7] Montanaro L,Brigotti M,Clohessy J,et al.Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer.J Pathol,2006,210(1):10-18. [8] Montanaro L,Tazzari PL,Derenzini M.Enhanced telomere shortening in transformed lymphoblasts from patients with X linked dyskeratosis.J Clin Pathol,2003,56 (8):583-586. [9] Safa WF,Lestringant GG,Frossard PM.X-linked dyskeratosis congenita:restrictive pulmonary disease and a novel mutation.Thorax,2001,56(11):891-894. [10] Yoshimoto T,Yanabe Y,Mizukami T,et al.Genetic analysis of a patient with dyskeratosis congenital Rinsho Ketsueki,2000,41 (6):524-529. [11] Knight SW,Heiss NS,Vulliamy TJ,et al.Unexplained aplastic anaemia,immunodeficiency,and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenitagene,DKC1.Br J Haematol,1999,107 (2):335-339. [12] Lin JH,Lee JY,Tsao CJ,et al.DKC1 gene mutation in a Taiwanese kindred with X-linked dyskeratosis congenita.Kaohsiung J Med Sci,2002,18(11):573-577. [13] Ding YG,Zhu TS,Jiang W,et al.Identification of a novel mutation and a de novo mutation in DKC1 in two Chinese pedigrees with Dyskeratosis congenita.J Invest Dermatol,2004,123 (3):470-473. [14] Heiss NS,Megarbane A,Klauck SM,et al.One novel and two recurrent missense DKC1 mutations in patients with dyskeratosis congenita (DKC).Genet Couns,2001,12 (2):129-136. [15] Knight SW,Vulliamy TJ,Morgan B,et al.Identification of novel DKC1 mutations in patients with dyskeratosis congenita:implications for pathophysiology and diagnosis.Hum Genet,2001,108 (4):299-303. [16] Vulliamy TJ,Marrone A,Knight SW,et al.Mutations in dyskeratosis congenita:their impact on telomere length and the diversity of clinical presentation.Blood,2006,107 (7):2680-2685. [17] Kanegane H,Kasahara Y,Okamura J,et al.Identification of DKC1 gene mutations in Japanese patients with X-linked dyskeratosis congenita.Br J Haematol,2005,129 (3):432-434. [18] Kraemer DM,Goebeler M.Missense mutation in a patient with X-linked dyskeratosis congenita.Haematologica,2003,88 (4):ECR11.. [19] Ly H,Schertzer M,Jastaniah W,et al.Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita.Blood,2005,106(4):1246-1252. [20] Ip P,Knight R,Dokal I,et al.Peripheral neuropathy-a novel finding in dyskeratosis congenita.Eur J Paediatr Neurol,2005,9 (2):85-89. [21] Harley CB.Telomerase therapeutics for degenerative diseases.Curr Mol Med,2005,5 (2):205-211. [22] Ayas M,Al-Musa A,Al-Jefri A,et al.Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low-dose cyclophosphamide and anti-thymocyte globulin.Pediatr Blood Cancer,2005,29 (3):231-233. [23] M'kacher R,Laithier V,Valent A,et al.Sensitivity to radiation and alkylating agent of peripheral lymphocytes and fibroblasts in a Hoyeraal-Hreidarsson syndrome patient.Pediatr Hematol Oncol,2003,20 (8):651-656. [24] Stein SM,Dale DC.Molecular basis and therapy of disorders associated with chronic neutropenia.Curr Allergy Asthma Rep,2003,3 (5):385-388. [25] Yilmaz K,Inaloz HS,Unal B,et al.Dyskeratosis congenita with isolated neutropenia and granulocyte colony-stimulating factor treatment.Int J Dermatol,2002,41 (3):170-172. 通讯作者: 王建琴,email:jianqinwang@tom.com